Ethical issues in drug testing, approval, and pricing
the clot-dissolving drugs
Our rough guess is there are 67,000 words in this book.
At a pace averaging 250 words per minute, this book will take 4 hours and 28 minutes to read. With a half hour per day, this will take 9 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
Author
Publication
1995 - Oxford University Press, New York, New York (State)
Language
English
Word Count
67,000 words, Guess
Page Count
268 pages
Identifiers
- Internet Archiveethicalissuesind0000brod
- ISBN-10019508831X
- ISBN-139780195088311
- LibraryThing6322305
- Goodreads273320
and 4 more
- Library of Congress Control Number94004479
- OCLC Control Number29877585
- Better World Books9780195088311
- Open LibraryOL1080959M
Classifications
- DDC174/.2
- LCCRM340 .B76 1995
- LCCRM340.B76 1995
Description
Although most developed countries have extensive regulations governing the testing, approval and marketing of new drugs, there are major gaps in these regulations. In this compelling new volume, Dr. Brody uses the example of the development of thrombolytic drugs to identify several such gaps. Issues addressed include the use of placebo control groups in clinical trials, the importance of determining the type of consent that should be obtained for emergency research, and ways to avoid conflicts of interest in clinical trials. He also discusses topics such as deciding to continue clinical trials or to approve a drug quickly, maintaining a proper balance between efficacy and safety in drug approval, the pricing of new drugs and considering prices when ordering drugs. This work offers the first comprehensive analysis from an ethical perspective of the entire drug development process, and it does so while comparing American and European approaches to the process.
Subjects
Topics
Other Editions
- Ethical issues in drug testing, approval, and pricing: the clot-dissolving drugs
Similar Books
The Truth About the Drug Companies: How They Deceive Us and What to Do About It
Marcia Angell
Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities
Board on Health Sciences Policy, Institute of Medicine, Strategies for Responsible Sharing of Clinical Trial Data
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!